Bone Therapeutics to strategically focus on lead cell therapy product ALLOB
REGULATED INFORMATION Strategic focus revised and fully focused on achieving topline results of the ALLOB Phase IIb study in tibial fractures. Discussions for ALLOB global partnership still ongoing. Board of Directors and Management...